|
Market Closed -
Nasdaq
00:00:00 05/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 8.240 USD | -3.85% |
|
-1.55% | +5.64% |
| 11-04 | BioCryst Pharmaceuticals, Inc., Q3 2026 Earnings Call, Nov 04, 2026 | |
| 11-04 | Wedbush Adjusts BioCryst Pharmaceuticals PT to $17 From $18, Maintains Outperform Rating | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BCRX | Delayed | |
CBOE
| BCRX | Real-time | |
|
Tradegate
| BO1 | Real-time | |
|
Mexican S.E.
| BCRX * | End-of-day quote | |
|
Deutsche Boerse AG
| BO1 | Delayed | |
|
Börse Stuttgart
| BO1 | Delayed | |
|
Boerse Muenchen
| BO1 | Real-time | |
|
Berne S.E.
| BO1 | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Neutral |
| Resistance | 8.59 | 9.55 | 10.45 |
| Spread/Res. | -4.07% | -13.72% | -21.15% |
| Spread/Supp. | +7.71% | +7.71% | +29.15% |
| Support | 7.65 | 7.65 | 6.38 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BCRX Stock
- Charts BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
